Physician profile
Jonathon Struemph
NPI 1598085680
$1,713.31
in general payments reported to CMS, 2019-2025
15 companies · $24.73 in 2025
The $24.73 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $255 · 2021: $164 · 2022: $623 · 2023: $142 · 2024: $221 · 2025: $24.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $388.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $637.72 | 2019-2024 | Mako, Blueprint Patient Specific Instrumentation |
| Zimmer Biomet Holdings, INC. | $323.66 | 2021-2022 | |
| Depuy Synthes Sales INC. | $198.53 | 2019-2024 | Monovisc |
| Pacira Pharmaceuticals Incorporated | $103.48 | 2019-2024 | Iovera, Exparel, Zilretta |
| Abbott Laboratories | $99.71 | 2022 | |
| Djo, LLC | $75.65 | 2019 | |
| Orthofix Medical, INC. | $57.54 | 2019-2021 | |
| Bioventus LLC | $36.86 | 2019-2022 | |
| Tactile Systems Technology INC | $35.38 | 2023 | Flexitouch Plus, Entre Plus |
| Smith+Nephew, INC. | $30.78 | 2024 | Pico 14 |
| Ferring Pharmaceuticals INC. | $26.30 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $25.21 | 2019 | |
| Baxter Healthcare | $24.73 | 2025 | Perclot |
| Ermi LLC | $22.51 | 2022 | |
| Avanos Medical | $15.25 | 2023 | On-Q* Pump and Accessories |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathon Struemph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.